You just read:

New Head-to-Head Data Show Taltz® (ixekizumab) Superiority versus TREMFYA® (guselkumab) in People with Moderate to Severe Plaque Psoriasis

News provided by

Eli Lilly and Company

Oct 03, 2019, 06:45 ET